American Academy of Family Physicians
About UsNews & PublicationsMembersCME CenterClinical & ResearchPractice MgmtPolicy & AdvocacyCareers

Provisional Recommendation

Immunize Adults Against Shingles, Says AAFP

By News Staff
12/6/2006

The Academy went proactive when on Nov. 29, AAFP Board Chair Larry Fields, M.D., of Flatwoods, Ky., approved a provisional immunization recommendation that adults 60 and older receive a single dose of varicella zoster vaccine, regardless of whether they report a previous episode of herpes zoster. The recommendation, which was forwarded to the board chair from the AAFP Commission on Science, is intended to prevent development of herpes zoster, commonly known as shingles, and post-herpetic neuralgia in this population.

Fields' approval of the commission's recommendation is in keeping with a relatively new process that allows the Academy to develop and issue its own provisional immunization recommendations based on a review of provisional recommendations created by the CDC's Advisory Committee on Immunization Practices, or ACIP.

On Oct. 25, the ACIP gave a thumbs-up to provisional recommendations (PDF file: 1 page / 22 KB. More about PDFs.) for the use of live, attenuated varicella zoster virus vaccine for prevention of herpes zoster and post-herpetic neuralgia. Those recommendations will become official when approved by the CDC and published in Morbidity and Mortality Weekly Report. At press time, the expected MMWR publication date was June 2007.

Family physicians Jonathan Temte, M.D., Ph.D., of Madison, Wis., and Doug Campos-Outcalt, M.D., M.P.A., of Phoenix, who serve as AAFP liaisons to the ACIP, agree with the recommendations, which also call for persons with chronic medical conditions to receive the vaccine unless a contraindication or precaution exists for their condition. Information about contraindications to and precautions regarding use of zoster vaccine can be found on the FDA's Web site.

Clinical Care & Research

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Pregnant Women

FDA Revises Diabetes Drug Prescribing Information

H1N1 Vaccine Availability Increasing Slowly

ACIP Supports 'Permissive Use' of Gardasil in Males

CDC Survey Shows Overall Gains in Teens' Immunization Rates

FDA Approves Gardasil for Males, Bivalent HPV Vaccine for Girls, Women

New USP Standards for Heparin Decrease Unit Dose Potency

H1N1 Vaccine Deliveries Begin This Week

Clinical Trial of H1N1 in Kids, Teens Shows Mixed Results

Physicians Should Use Caution With Tamiflu Dosages

Prostate Cancer Awareness Campaigns Could Cause Confusion

Federal Health Officials Push H1N1 Vaccine for Adults, Health Workers

IOM: N95 Respirators Offer H1N1 Flu Defense for Health Personnel

CDC Updates Recommendations for Antiviral Use

CDC Updates Guidance on Ophthalmia Neonatorum Prophylaxis

New AHRQ Guides Outline Gestational Diabetes Treatment Options

Erythromycin Ophthalmic Ointment in Short Supply

CDC, FDA Study Reinforces Safety, Efficacy of Gardasil

New GSK Product Should Ease Hib Vaccine Shortage

H1N1 Vaccine Clinical Trials in Adults Free of Adverse Events

AAFP Launches Awareness Campaign for Pertussis Vaccination

H1N1 Vaccine Production Lagging Behind Expectations

FDA Issues Multiple Safety Alerts, Updates

ACIP Updates Poliovirus Vaccination Recommendations

Research Network Seeks Evidence to Support Collaborative Care

Vaccines & Immunizations Special Report

ACIP Issues Targeted Recommendations for H1N1 Vaccinations

CDC Pushes Seasonal Flu Shots for Kids Ages 6 Months to 18 Years